<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 48-year-old Kenyan African, who presented with a history of coronary and <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e>, was found to have <z:hpo ids='HP_0006685'>endomyocardial fibrosis</z:hpo> of the left ventricle </plain></SENT>
<SENT sid="1" pm="."><plain>It proved possible to remove <z:hpo ids='HP_0000001'>all</z:hpo> diseased tissue at operation, and at the same time to preserve the mitral valve </plain></SENT>
<SENT sid="2" pm="."><plain>It is important to inspect the mitral valve from both the atrial and ventricular aspects so that the valve can be spared, if it is not involved in the disease process </plain></SENT>
<SENT sid="3" pm="."><plain>The choice of transatrial of transventricular surgical approach for the removal of pathological tissue may depend on whether or not the mitral valve requires replacement </plain></SENT>
</text></document>